The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Induction of interferon‐α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG
Abstract
Objective: To investigate the release of interferon‐α (IFNα)–inducing material by necrotic or apoptotic cells, its properties, and the necessity of autoantibodies from systemic lupus erythematosus (SLE) patients for the interferogenic activity. Methods: U937 monocytic leukemia cells or peripheral blood mononuclear cells (PBMCs) were rendered necrotic by freeze‐thawing or apoptotic by treatment with ultraviolet light. Cell culture supernatants from these cells and IgG from SLE patients (SLE IgG) were added to cultures of normal PBMCs or purified plasmacytoid dendritic cells (PDCs). The importance of nucleic acids for IFNα induction was investigated by RNase and DNase treatment. The IFNα levels were measured by immunoassay. Results: Both necrotic and apoptotic U937 cells released material that, combined with SLE IgG, induced IFNα production in PDCs. The release from apoptotic cells occurred with a 16‐hour delay, in late apoptosis. Also, normal PBMCs released IFNα‐inducing material, but only during necrosis. The interferogenic activity of the necrotic material required the presence of RNA, while both RNA and DNA were important in the apoptotic material. In both cases, the presence of SLE IgG was necessary, and its activity correlated with the presence of antibodies to RNA‐binding proteins, but not anti‐DNA antibodies. Conclusion: Necrotic and late apoptotic cells release material that, combined with SLE IgG, induces production of IFNα in PDCs. The IFNα inducers probably consist of immune complexes (ICs) containing RNA and possibly DNA as essential interferogenic components. The presence of such interferogenic ICs could explain the ongoing production of IFNα in SLE and could be of etiopathogenic importance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,240
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,358
Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D. W., & Schmitz, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6037 · Cited by 1,298
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 974
Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., & Hartmann, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2154::aid-immu2154>3.0.co;2-u · Cited by 882
Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., & Kalden, J. R. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1241::aid-art15>3.0.co;2-h · Cited by 839
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., & Jahnsen, F. L. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61689-6 · Cited by 730
Ahmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717
Gershov, D., Kim, S., Brot, N., & Elkon, K. B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1353 · Cited by 695
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 667
Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells
Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N. J., Trapani, J., & Cebon, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1947 · Cited by 611
Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
Emlen, W., Niebur, J., & Kadera, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3685 · Cited by 552
Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis
Van Cruchten, S., & Van den Broeck, W. (2002) · Anatomia, Histologia, Embryologia · doi:10.1046/j.1439-0264.2002.00398.x · Cited by 547
Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., & Fukuhara, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020207 · Cited by 466
Bengtsson, A. A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., & Rönnblom, L. (2000) · Lupus · doi:10.1191/096120300674499064 · Cited by 464
Self-citationSystemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon
Preble, O. T., Black, R. J., Friedman, R. M., Klippel, J. H., & Vilček, J. (1982) · Science · doi:10.1126/science.6176024 · Cited by 459
Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., & Beg, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7128 · Cited by 432
Serum interferon levels in patients with systemic lupus erythematosus
Ytterberg, S. R., & Schnitzer, T. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250407 · Cited by 382
Båve, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G. V., & Rönnblom, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3296 · Cited by 380
Self-citationRÖNNBLOM, L. E., ALM, G. V., & ÖBERG, K. E. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00144.x · Cited by 360
Self-citationCytokines as a link between innate and adaptive antitumor immunity
Belardelli, F. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02195-6 · Cited by 322
Molecular mechanisms of UV-induced apoptosis
Kulms, D., & Schwarz, T. (2000) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1034/j.1600-0781.2000.160501.x · Cited by 319
Vallin, H., Perers, A., ALM, G. V., & Rönnblom, L. (1999) · PubMed · Cited by 284
Self-citationThe function of type I interferons in antimicrobial immunity
Bogdan, C. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00111-4 · Cited by 276
IFN‐α/β enhances BCR‐dependent B cell responses
Braun, D., Caramalho, I., & Demengeot, J. (2002) · International Immunology · doi:10.1093/intimm/14.4.411 · Cited by 268
Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D., & Glaspy, J. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.358 · Cited by 262
Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6306 · Cited by 256
Self-citationVALLIN, H., BLOMBERG, S., ALM, G. V., CEDERBLAD, B., & RÖNNBLOM, L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00772.x · Cited by 252
Self-citationCurrent evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
Ioannou, Y., & Isenberg, D. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200007)43:7<1431::aid-anr3>3.0.co;2-e · Cited by 252
Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus
Blomberg, S., Eloranta, M. L., Cederblad, B., Nordlind, K., Alm, G. L., & Rönnblom, L. (2001) · Lupus · doi:10.1191/096120301678416042 · Cited by 230
Self-citationCederblad, B., Blomberg, S., Vallin, H., Perers, A., Alm, G. V., & Rönnblom, L. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0215 · Cited by 215
Self-citationPerniok, A., Wedekind, F., Herrmann, M., Specker, C., & Schneider, M. (1998) · Lupus · doi:10.1191/096120398678919804 · Cited by 212
Seckel, M. A. (2003) · Clinical Nurse Specialist · doi:10.1097/00002800-200311000-00015 · Cited by 212
Role of DNA Methylation in the Regulation of Cell Function: Autoimmunity, Aging and Cancer
Richardson, B. C. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2401s · Cited by 204
An etiopathogenic role for the type I IFN system in SLE
Rönnblom, L., & Alm, G. V. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01955-x · Cited by 197
Self-citationAmoura, Z., Piette, J., Chabre, H., Cacoub, P., Papo, T., Wechsler, B., Bach, J., & Koutouzov, S. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401217 · Cited by 179
The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer
Båve, U., Alm, G. V., & Rönnblom, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3519 · Cited by 167
Self-citationBlomberg, S., Eloranta, M., Magnusson, M., Alm, G. V., & Rönnblom, L. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11225 · Cited by 150
Self-citationImmune-Mediated Complications during Interferon Therapy in Hematological Patients
Raanani, P., & Ben‐Bassat, I. (2002) · Acta Haematologica · doi:10.1159/000057631 · Cited by 123
Viral Double-Stranded RNA, Cytokines, and the Flu
Majde, J. A. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/107999000312397 · Cited by 120
Natural Interferon-α Producing Cells: The Plasmacytoid Dendritic Cells
Fitzgerald-Bocarsly, P. A. (2002) · BioTechniques · doi:10.2144/oct0203 · Cited by 119
Svensson, H., Johannisson, A., Nikkila, T., Alm, G. V., & CEDERBLAD, B. (1996) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1996.d01-289.x · Cited by 116
Self-citationThe natural interferon-α producing cells in systemic lupus erythematosus
Rönnblom, L., & Alm, G. V. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00757-7 · Cited by 112
Self-citationBåve, U., Vallin, H., Alm, G. V., & Rönnblom, L. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0519 · Cited by 104
Self-citationKälkner, K. M. (1998) · QJM · doi:10.1093/qjmed/91.6.393 · Cited by 104
Shoshan, Y., Shapira, I., Toubi, E., Frolkis, I., Yaron, M., & Mevorach, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5963 · Cited by 99
The first international standard for antibodies to double stranded DNA
Feltkamp, T. E., Kirkwood, T. B., Maini, R. N., & Aarden, L. A. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.9.740 · Cited by 97
Payvandi, F., Amrute, S. B., & Fitzgerald-Bocarsly, P. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5861 · Cited by 86
Payvandi, F., Amrute, S. B., & Fitzgerald-Bocarsly, P. A. (1998) · PubMed · Cited by 85
Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase
Ruuth, K., Carlsson, L., Hallberg, B., & Lundgren, E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5025 · Cited by 81
Magnusson, M., Magnusson, S., Vallin, H., Rönnblom, L., & Alm, G. V. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.01018.x · Cited by 74
Self-citationNewkirk, M. M., van Venrooij, W. J., & Marshall, G. S. (2001) · Arthritis Research & Therapy · doi:10.1186/ar310 · Cited by 65
Huck, S., Deveaud, E., Namane, A., & Zouali, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1415 · Cited by 59
Appearance of anti‐DNA antibodies in patients treated with interferon‐α
Ehrenstein, M. R., McSweeney, E. N., Swana, M., Worman, C. P., Goldstone, A. H., & Isenberg, D. A. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360224 · Cited by 56
Chernysheva, A., Kirou, K. A., & Crow, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1241 · Cited by 48
Viruses and autoimmune disease – two sides of the same coin?
Fujinami, R. S. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02097-2 · Cited by 42
Hylkema, M. N., Huygen, H., Kramers, C., der Wal, T. J. V., de Jong, J., van Bruggen, M. C. J., Swaak, A. J. G., Berden, J. H. M., & Smeenk, R. J. T. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90249-6 · Cited by 37
Gröndal, G., Traustadóttir, K. H., Kristjansdottir, H., Lundberg, I. E., Klareskog, L., Erlendsson, K., & Steinsson, K. (2002) · Lupus · doi:10.1191/0961203302lu223oa · Cited by 35
ANTIBODIES TO NONHISTONE ANTIGENS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Fritzler, M. J., & Chan, E. K. L. (2004) · Elsevier eBooks · doi:10.1016/b978-012433901-9/50016-8 · Cited by 6
Cited by
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Metadata
- Authors
- Lövgren, T., Eloranta, M., Båve, U., Alm, G. V., & Rönnblom, L.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-06
- Volume
- 50
- Issue
- 6
- Pages
- 1861-1872
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1973431560
- Cited by
- 552
- References
- 71
- FWCI
- 19.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.